CEACAM5 and rectal cancer: Sugarbaker and colleagues determined that serial carcinoembryonic antigen assays determined at 3 monthly intervals after a colon or rectal cancer resection would detect occult recurrent disease approximately 6 months prior to clinical signs and symptoms [10].